Childhood-Onset Schizophrenia: A Double-blind Clozapine-Haloperidol Comparison
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Childhood-onset schizophrenia is a rare but severe form of the disorder that is often treatment-refractory. In this study, the efficacy and adverse effects of clozapine and haloperidol were compared for children and adolescents with early-onset schizophrenia. METHODS: Twenty-one patients (mean [+/-SD] age, 14.0 +/- 2.3 years) with onset of Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition-defined schizophrenia that began by age 12 years and who had been nonresponsive to typical neuroleptics participated in the study. Patients were randomized to a 6-week double-blind parallel comparison of clozapine (mean [+/-SD] final dose, 176 +/- 149 mg/d), or haloperidol, (16 +/- 8 mg/d). RESULTS: Clozapine was superior to haloperidol on all measures of psychosis (P = .04-.002). Positive and negative symptoms of schizophrenia improved. However, neutropenia and seizures were major concerns. To date, one third of the group has discontinued using clozapine. CONCLUSIONS: Clozapine has striking superiority for positive and negative symptoms in treatment-refractory childhood-onset schizophrenia. However, due to possibly increased toxic effects in this pediatric population, close monitoring for adverse events is essential.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These medications remain of major importance, including clozapine, the most effective (and toxic) of all for childhood psychosis (46,47).”
From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [46]
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,264
Clozapine-induced agranulocytosis. incidence and risk factors in the united states
Alvir, J. M. J., Lieberman, J. A., Safferman, A. Z., Schwimmer, J. L., & Schaaf, J. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290303 · Cited by 967
Benes, F. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950060041004 · Cited by 744
Breier, A. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810270051007 · Cited by 626
BUNNEY, W. E. (1963) · Archives of General Psychiatry · doi:10.1001/archpsyc.1963.01720150090010 · Cited by 480
Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.1.20 · Cited by 388
Pickar, D. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820050009001 · Cited by 354
Cited by
Items 201–300 of 412
Cicala, G., Barbieri, M. A., Santoro, V., Tata, C., Colucci, P. V., Vanadia, F., Drago, F., Russo, C., Cutroneo, P. M., Gagliano, A., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00152 · Cited by 24
Management of Schizophrenia in Children and Adolescents: The Role of Clozapine
Remschmidt, H., Fleischhaker, C., Hennighausen, K., & Schulz, E. (2000) · Pediatric Drugs · doi:10.2165/00128072-200002040-00002 · Cited by 24
Falkai, P., Wobrock, T., Lieberman, J. A., Glenthoj, B. Y., Gattaz, W. F., & Möller, H. (2006) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832006000700003 · Cited by 44
CHILD AND ADOLESCENT SCHIZOPHRENIA
Schulz, S. C., Findling, R. L., Wise, A. L., Friedman, L., & Kenny, J. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70360-9 · Cited by 26
Schoenwald, S. K., & Rowland, M. D. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.003.0005 · Cited by 25
Geller, B., Tillman, R., Bolhofner, K., Hennessy, K., & Cook, E. H. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0056 · Cited by 26
Sikich, L., & Maloney (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6614 · Cited by 26
Psychopharmacologic Treatment of Schizophrenia in Adolescents and Children
Lee, E. S., Kronsberg, H., & Findling, R. L. (2019) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2019.08.009 · Cited by 23
Clark, A. F. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104040249 · Cited by 27
Evans, M. E., & Armstrong, M. I. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.003.0003 · Cited by 22
Management of treatment resistant schizophrenia
Jones, S., & Castle, D. J. (2006) · African Journal of Psychiatry · doi:10.4314/ajpsy.v9i1.30202 · Cited by 22
Dawkins, K., Lieberman, J. A., Lebowitz, B. D., & Hsiao, J. (1999) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033387 · Cited by 25
Schur, S. B., Sikich, L., Findling, R. L., Malone, R. P., Crismon, M. L., Derivan, A., MacIntyre, J. C., Pappadopulos, E. A., Greenhill, L. L., Schooler, N. R., et al. (2004) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.2.4.596 · Cited by 21
Ireys, H. T., DeVet, K. A., & Sakwa, D. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.003.0008 · Cited by 22
A review of the growing evidence base for pediatric psychopharmacology
Pappadopulos, E. A., Guelzow, B. T., Wong, C., Ortega, M., & Jensen, P. S. (2004) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2004.04.007 · Cited by 22
Taylor, D. L., Tiwari, A. K., Lieberman, J. A., Potkin, S. G., Meltzer, H. Y., Knight, J., Remington, G. J., Müller, D. J., & Kennedy, J. L. (2016) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2519 · Cited by 23
Jiménez‐Fernández, S., Gurpegui, M., Correll, C. U., de León, J., & Schoretsanitis, G. (2023) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001154 · Cited by 21
Pericarditis and Polyserositis as a Side Effect of Clozapine in an Adolescent Girl
Branik, E., & Nitschke, M. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/1044546041649039 · Cited by 20
Dumortier, G., Welniarz, B., Sauvebois, C., Medjdoub, H., Friche, H., Siad, N., & Degrassat, K. (2005) · L Encéphale · doi:10.1016/s0013-7006(05)82409-1 · Cited by 22
Atypical antipsychotics in the treatment of early-onset schizophrenia
Hrdlička, M., & Dudová, I. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s82185 · Cited by 19
Effectiveness and safety of antipsychotics in early onset psychoses: A long-term comparison
Cianchetti, C., & Ledda, M. G. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.03.020 · Cited by 20
Current status of clozapine in the United States.
Kelly, D. L., Wehring, H. J., & Vyas, G. R. (2012) · PubMed Central · doi:10.3969/j.issn.1002-0829.2012.02.007 · Cited by 19
Samara, M. T., Lappas, A. S., Pinioti, E., Glarou, E., Fober, I., Christogiannis, C., Siafis, S., Christodoulou, G. N., Helfer, B., Mavridis, D., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103291 · Cited by 18
Gentile, S. (2011) · Pediatric Drugs · doi:10.2165/11591250-000000000-00000 · Cited by 19
Childhood‐onset schizophrenia and tryptophan hydroxylase gene polymorphism
Sekizawa, T., Iwata, Y., Nakamura, K., Matsumoto, H., Suzuki, A., Suzuki, K., Sekine, Y., Takei, N., Minabe, Y., & Mori, N. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30009 · Cited by 18
Risky Business: Making Sense of Estimates of Risk
Streiner, D. L. (1998) · The Canadian Journal of Psychiatry · doi:10.1177/070674379804300411 · Cited by 18
Bailly, D. (2009) · L Encéphale · doi:10.1016/s0013-7006(09)75527-7 · Cited by 21
Weisinger, B., GREENSTEIN, D. K., Mattai, A. A., CLASEN, L. S., Lalonde, F. M., Feldman, S. J., Miller, R., Tossell, J. W., Vyas, N. S., Stidd, R., et al. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr049 · Cited by 17
Management of Adverse Effects of Second-generation Antipsychotics in Youth
Raffin, M., Gianitelli, M., Consoli, A., Bonnot, O., Ménard, M.-L., Askenazy-Gittard, F., Laurent‐Levinson, C., & Cohen, D. (2014) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-013-0007-9 · Cited by 19
The use of antipsychotics in preschoolers: A veto or a sensible last option?
Memarzia, J., Tracy, D. K., & Giaroli, G. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113519506 · Cited by 17
Reasons for Hope for Children and Families: A Perspective and Overview
Burns, B. J. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.003.0001 · Cited by 17
Proposed treatment for adolescent psychosis. 1: Schizophrenia and schizophrenia-like psychoses
Clark, A. F. (2001) · Advances in Psychiatric Treatment · doi:10.1192/apt.7.1.16 · Cited by 17
Leponex®, 10 ans après – Une revue clinique
Llorca, P., & Péré, J.-J. (2004) · L Encéphale · doi:10.1016/s0013-7006(04)95462-0 · Cited by 17
Sacchetti, E., Panariello, A., Regini, C., & Valsecchi, P. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00225-1 · Cited by 17
Psychopharmacology of Schizophrenia in Children and Adolescents
Carlisle, L. L., & McClellan, J. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2010.11.006 · Cited by 16
The Diagnosis and Treatment of Children and Adolescents with Schizophrenia
Kumra, S. (2000) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30141-x · Cited by 17
Self-citationEmpirical Evidence for Psychopharmacologic Treatment in Early-Onset Psychosis and Schizophrenia
Maloney, A. E., Yakutis, L., & Frazier, J. A. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.07.011 · Cited by 16
Pagsberg, A. K., Jeppesen, P., Klauber, D. G., Jensen, K. G., Rudå, D., Stentebjerg-Olesen, M., Jantzen, P., Rasmussen, S., Saldeen, E. A.-S., Lauritsen, M.-B. G., et al. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-199 · Cited by 16
Pinioti, E., Glarou, E., Lappas, A. S., Fober, I., Helfer, B., Siafis, S., Christodoulou, G. N., Nikolakopoulou, A., Leucht, S., & Samara, M. T. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2025.10421 · Cited by 14
Yee, C. S., Bahji, A., Lolich, M., Vázquez, G. H., & Baldessarini, R. J. (2022) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001506 · Cited by 14
Brasil, H. H. A., & Filho, J. F. B. (2000) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462000000600012 · Cited by 14
Un trouble rare et peu étudié : la schizophrénie chez l’enfant. À propos d’une observation
Bailly, D., & de lenclave, M.-B. D. C. (2004) · L Encéphale · doi:10.1016/s0013-7006(04)95468-1 · Cited by 14
Neuronal glucose metabolism and schizophrenia: therapeutic prospects?
Dwyer, D. S., Lu, X., & Freeman, A. M. (2003) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.3.1.29 · Cited by 14
An Open-Label Study of Olanzapine in Children and Adolescents with Schizophrenia
Quintana, H., WILSON, M. S., Purnell, W., Layman, A. K., & Mercante, D. (2007) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000265765.25495.e0 · Cited by 14
Treatment and outcomes in adolescents with schizophrenia.
Schulz, S. C., Findling, R. L., Friedman, L., Kenny, J. T., & Wise, A. L. (1998) · PubMed · Cited by 14
HLA antigens in childhood onset schizophrenia
Jacobsen, L. K., Mittleman, B. B., Kumra, S., Lenane, M., Barracchini, K. C., Adams, S. D., Simonis, T. B., Lee, P. R., Long, R. T. L., Sharp, W. S., et al. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(98)00015-8 · Cited by 14
Self-citationEvaluierte Behandlungsansätze in der Kinder- und Jugendpsychiatrie I
Baving, L., & Schmidt, M. H. (2001) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024//1422-4917.29.3.189 · Cited by 22
Clozapine Treatment for Aggressive Behaviors in Youths with Neurodevelopmental Disorders
Berloffa, S., Masi, G., Falcone, F., Simonelli, V., Narzisi, A., Valente, E., Viglione, V., Milone, A., & Sesso, G. (2024) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2023.0097 · Cited by 13
Prescribing antipsychotics for children and adolescents
James, A. C. (2010) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.108.005652 · Cited by 14
Treatment-refractory schizophrenia: what is it and what has been done about it?
Citrome, L. (2011) · Neuropsychiatry · doi:10.2217/npy.11.35 · Cited by 13
Hallucinations de l’enfant et de l’adolescent
Jardri, R., Bonelli, F., Askenazy-Gittard, F., Georgieff, N., & Delion, P. (2013) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(13)58150-8 · Cited by 14
Special Education: Best Practices and First Step to Success
Epstein, M. H., & Walker, H. M. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.003.0009 · Cited by 16
David, C. N., Rapoport, J. L., & Gogtay, N. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.29 · Cited by 12
Teixeira, E. H., Jacintho, A. C. D. Á., Celeri, E. H. R. V., & Dalgalarrondo, P. (2013) · Trends in Psychiatry and Psychotherapy · doi:10.1590/s2237-60892013000300002 · Cited by 13
Coghill, D. (2003) · Advances in Psychiatric Treatment · doi:10.1192/apt.9.4.289 · Cited by 13
Antipsychotic Use in Children and Adolescents: Minimizing Adverse Effects to Maximize Outcomes
Correll, C. U. (2008) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.6.3.foc368 · Cited by 12
Kufert, Y., Ebert, T., Kosov, I., Kotler, M., Weizman, A., & Ram, A. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0050 · Cited by 12
Atypical Antipsychotic Drugs in Treatment-Refractory Schizophrenia
Bradford, D. W., Chakos, M., Sheitman, B., & Lieberman, J. A. (1998) · Psychiatric Annals · doi:10.3928/0048-5713-19981101-06 · Cited by 12
Use of antipsychotics by child and adolescent psychiatrists
Slaveska-Hollis, K., Hollis, C. P., & Bramble, D. J. (1998) · Psychiatric Bulletin · doi:10.1192/pb.22.11.685 · Cited by 12
Atypical Antipsychotics for Treatment of Schizophrenia Spectrum Disorders
Cullen, K. R., Kumra, S., Westerman, M., & Schulz, S. C. (2008) · The Psychiatric times · Cited by 11
Self-citationCheine, M. V., Wahlbeck, K., & Rimón, M. (1999) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651509909022729 · Cited by 11
Clozapine in Childhood-Onset Schizophrenia: A Report of Five Cases
Malhotra, S., Gupta, N., & Singh, G. (2000) · Clinical Child Psychology and Psychiatry · doi:10.1177/1359104500005003009 · Cited by 10
Child and Adolescent Psychiatric Disorders
Bostic, J. Q., & Prince, J. B. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50071-8 · Cited by 10
Berel, C., Mossé, U., Wils, J., Cousin, L., Imbert, L., Gérardin, P., Chaumette, B., Lamoureux, F., & Ferrafiat, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.669446 · Cited by 10
La schizophrénie infantile : données actuelles et principes de prise en charge thérapeutique
Fourneret, P., Georgieff, N., & Franck, N. (2013) · Archives de Pédiatrie · doi:10.1016/j.arcped.2013.04.021 · Cited by 13
Shaw, P., & Rapoport, J. L. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000251618.25248.00 · Cited by 10
Child and Adolescent Psychopharmacology
Wilens, T. E., Spencer, T. J., Frazier, J. A., & Biederman, J. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5905-4_25 · Cited by 11
Hollis, C. P., & Palaniyappan, L. K. (2015) · Wiley eBooks · doi:10.1002/9781118381953.ch57 · Cited by 11
Abbs, B., Achalia, R. M., Adelufosi, A. O., Aktener, A. Y., Beveridge, N. J., Bhakta, S. G., Blackman, R. K., Bora, E., Byun, M. S., Cabanis, M., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.07.024 · Cited by 11
Lost in Translation: Challenges in the Diagnosis and Treatment of Early-Onset Schizophrenia
Gupta, N., Gupta, M., & Esang, M. (2023) · Cureus · doi:10.7759/cureus.39488 · Cited by 10
Management of early-onset psychosis
Shaw, M., & Singh, S. P. (2004) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000133826.11672.0b · Cited by 10
Mentoring to Facilitate Resiliency in High-Risk Youth
Vance, J. E. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.003.0007 · Cited by 9
Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY) Part II
Pappadopulos, E. A., MacIntyre, J. C., Crismon, M. L., Findling, R. L., Malone, R. P., Derivan, A., Schooler, N. R., Sikich, L., Greenhill, L. L., Schur, S. B., et al. (2004) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.2.4.608 · Cited by 9
Schizophrenia in Pre-school Children: Two Case Reports With Longitudinal Follow-up for 6 and 8 Years
Beresford, C. A., Hepburn, S., & Ross, R. G. (2005) · Clinical Child Psychology and Psychiatry · doi:10.1177/1359104505053759 · Cited by 8
Fraguas, D., Merchán‐Naranjo, J., & Arango, C. (2010) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2010.08.001 · Cited by 8
Tang, S., Ansarian, A., & Courtney, D. (2017) · PubMed · Cited by 13
Early onset schizophrenia: diagnostic dilemmas and treatment challenges
Shannon, J. C., & McClellan, J. (2004) · Therapy · doi:10.2217/14750708.1.1.131 · Cited by 8
Efficacy and safety of long-acting risperidone on early onset schizophrenia in adolescent patients
Ruan, L., Hu, S., Huang, M., Hu, J., & Cai, W. (2010) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp.9000132 · Cited by 8
New Findings on Antipsychotic Use in Children and Adolescents With Schizophrenia Spectrum Disorders
Ross, R. G. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08081180 · Cited by 8
Management of Clozapine-Induced Fever in a Child
Driver, D. I., Anvari, A. A., Peroutka, C. M., Kataria, R., Overman, J., Lang, D., Tietcheu, M., Parker, R., Baptiste, K., Rapoport, J. L., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13070866 · Cited by 7
Managing Psychotic Illness in Young People: A Practical Overview
Tiffin, P. A. (2006) · Child and Adolescent Mental Health · doi:10.1111/j.1475-3588.2006.00418.x · Cited by 8
Youth-onset schizophrenia: psychopathology, clinical presentation and therapy
Каледа, В. Г. (2015) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201511511226-33 · Cited by 8
Retrospective Review of Clozapine Use in Children and Adolescents.
Komaryk, A. L. D., Elbe, D., & Burgess, L. (2021) · PubMed · Cited by 7
Missed Diagnosis of Tardive Dystonia in an Adolescent Girl Treated with Risperidone
Pringsheim, T. M. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0122 · Cited by 7
Kumra, S., Asarnow, R. F., Grace, A. A., Keshavan, M. S., McClellan, J., Sikich, L., & Wagner, A. (2009) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2009.00142.x · Cited by 8
Self-citationEvaluierte Behandlungsansätze in der Kinder- und Jugendpsychiatrie II
Baving, L., & Schmidt, M. H. (2001) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024//1422-4917.29.3.206 · Cited by 13
Bhatara, V. S., Gupta, S., & Flugsrud-Breckenridge, M. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.1.90 · Cited by 7
Do we need placebos to evaluate new drugs in children with schizophrenia?
Armenteros, J. L., & Mikhail, A. G. (2001) · Psychopharmacology · doi:10.1007/s00213-001-0928-7 · Cited by 6
Baharnoori, M., Bartholomeusz, C., Boucher, A. A., Buchy, L., Chaddock, C., Chiliza, B., Föcking, M., Fornito, A., Gallego, J. A., Hori, H., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.09.008 · Cited by 8
The Pharmacologic Treatment of the Early Phase of First-Episode Psychosis in Youths
Walter, G., Wiltshire, C., Anderson, J., & Storm, V. (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674370104600903 · Cited by 9
Weaver, L., León, D. D. D., Borgmann‐Winter, K. E., & Coffey, B. J. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.2022 · Cited by 6
(2005) · CRC Press eBooks · doi:10.1201/b14455-6 · Cited by 6
Xu, Y., Nguyen, D., Davidson, J., & Panagiotopoulos, C. (2012) · Europe PMC (PubMed Central) · Cited by 6
Child and Adolescent Onset Schizophrenia
Hollis, C. P. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch4 · Cited by 5
Current Treatment Trends of Psychosis in Youth with Schizophrenia
Baker, K. K., Howell, C., & Findling, R. L. (2016) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-016-0066-9 · Cited by 6
Karaçetin, G., Ermiş, Ç., Koç, E. B., & Sağlam, Y. (2021) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2021.0009 · Cited by 5
Stratégies diagnostiques et thérapeutiques face aux hallucinations de l’enfant et de l’adolescent
Jardri, R., Delion, P., & Goëb, J.-L. (2009) · La Presse Médicale · doi:10.1016/j.lpm.2009.09.010 · Cited by 5
The first-episode of schizophrenia: a challenge for treatment
Fleischhacker, W. W. (2002) · European Psychiatry · doi:10.1016/s0924-9338(03)00076-2 · Cited by 5
Psychopharmacology of conduct disorder: current progress and future directions
Tcheremissine, O., Cherek, D. R., & Lane, S. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.5.1109 · Cited by 6
Modifying the risk of atypical antipsychotics in the treatment of juvenile-onset schizophrenia
Townsend, L. D., & Findling, R. L. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903473165 · Cited by 5
Metadata
- Authors
- Kumra, S.
- Affiliations
- National Institute of Mental Health (US)
- Corresponding author
- Kumra, Sanjiv
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1996-12-01
- Volume
- 53
- Issue
- 12
- Pages
- 1090
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2125778283
- Cited by
- 410
- References
- 53
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 8 · 2023: 5 · 2022: 2 · 2021: 8 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 3 · 2016: 13 · 2015: 5 · 2014: 7 · 2013: 19 · 2012: 23
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- childhood schizophrenia, clozapine, haloperidol, treatment-resistant schizophrenia, antipsychotic efficacy, adverse drug reactions, neutropenia, seizures, positive and negative symptoms, child psychiatry, atypical antipsychotics
- MeSH terms
- Adolescent, Age Factors, Child, Child, Preschool, Clozapine, Double-Blind Method, Drug Administration Schedule, Haloperidol, Humans, Neutropenia, Psychiatric Status Rating Scales, Schizophrenia, Childhood, Seizures, Severity of Illness Index, Treatment Outcome, Age of Onset
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.